» Articles » PMID: 37935895

Immune Response Profiling of Cocktails of Brugia Malayi Vaccine Candidates DIM-1, Calponin and Troponin 1 in BALB/c Mice

Overview
Journal Acta Parasitol
Specialty Parasitology
Date 2023 Nov 7
PMID 37935895
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: In search of a vaccine for the control of human lymphatic filariasis (LF) caused by Wuchereria bancrofti, Brugia malayi and B. timori, we identified three parasite-specific potential candidates: the disorganized muscle protein-1 (D), calponin (C) and troponin 1 (T) in B. malayi adult worm. In the present study, we investigated the immune response profile of the cocktails of the recombinant D, T and C proteins.

Methods: Groups of BALB/c mice were immunized with individual rproteins or their cocktails DT, TC, DC and DTC, and the immunogen-specific IgG and its subclasses and IgE were determined. Cells from the immunized animals were challenged in vitro with the respective rproteins and cocktails and the release of nitric oxide (NO) from macrophages and Th1 and Th2 cytokines from splenocytes were determined.

Results: Among the immunized groups, DTC elicited comparatively a stronger response which included augmented release of NO, Th1 (IL-1β, IL-2, IFN-γ and TNF-α) and Th2 (IL-4, IL-6, IL-10 and TGF-β) cytokines, and increased levels of immunogen-specific IgG, IgG1 and IgG2b and low levels of immunogen-specific IgG2a and IgE and the Th2 cytokine IL-13.

Conclusion: Immune responses that play important role in host protection were elicited strongly by DTC cocktail compared to the individual rproteins or DT, TC and DC cocktails. The findings provide a sound rationale for further studies on DTC cocktail as a vaccine candidate for the control of LF.

References
1.
Babu S, Nutman T . Immunology of lymphatic filariasis. Parasite Immunol. 2013; 36(8):338-46. PMC: 3990654. DOI: 10.1111/pim.12081. View

2.
Raju K, Jambulingam P, Sabesan S, Vanamail P . Lymphatic filariasis in India: epidemiology and control measures. J Postgrad Med. 2010; 56(3):232-8. DOI: 10.4103/0022-3859.68650. View

3.
Taylor M, Hoerauf A, Bockarie M . Lymphatic filariasis and onchocerciasis. Lancet. 2010; 376(9747):1175-85. DOI: 10.1016/S0140-6736(10)60586-7. View

4.
Rao R, Samarasekera S, Nagodavithana K, Dassanayaka T, Punchihewa M, Ranasinghe U . Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka. PLoS Negl Trop Dis. 2017; 11(10):e0006066. PMC: 5679644. DOI: 10.1371/journal.pntd.0006066. View

5.
Babayan S, Allen J, Taylor D . Future prospects and challenges of vaccines against filariasis. Parasite Immunol. 2011; 34(5):243-53. DOI: 10.1111/j.1365-3024.2011.01350.x. View